Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Multiply Labs
AddedMar 17, 2024
UpdatedJul 3, 2026
Multiply Labs

Multiply Labs

Series A

Multiply Labs: Robotic systems for scalable, cost-effective pharma manufacturing.

HQ
San Francisco, CA, US
Founded
2016
Accelerator
NVIDIA Inception logoNVIDIA InceptionMember
Accelerator
Y Combinator logoY CombinatorS16
Overview
Compare
Fundraising
Employees
Website

Multiply Labs aims to revolutionize the pharma manufacturing industry by deploying cloud-controlled modular robotic systems to produce individualized drugs at scale. Their technology addresses the inefficiencies of traditional manual processes, making precision medicines more accessible and affordable. The company focuses on manufacturing gene-modified cell therapies and other precision medicines, offering flexible, high-throughput solutions compatible with GMP instruments.

Multiply Labs has made significant strides in the life sciences sector, establishing itself as a key player in cell therapy manufacturing. Their advanced robotic systems have been adopted by leading pharma companies, enhancing production efficiency and scalability. The company's innovative approach has garnered attention and support from notable investors and industry leaders, solidifying its impact on the future of personalized medicine.

Multiply Labs - Similar Companies

Mytos logo

Mytos

mytos.bio

Orangewood Labs logo

Orangewood Labs

orangewood.co

Industrial Next logo

Industrial Next

industrialnext.ai

SkyMul logo

SkyMul

skymul.com

Rapid Robotics logo

Rapid Robotics

rapidrobotics.com

Advanced Robotics logo

Advanced Robotics

Modbot logo

Modbot

modbot.com

Sorting Robotics logo

Sorting Robotics

Bright Path Laboratories logo

Bright Path Laboratories

brightpathlabs.com

Machina Labs logo

Machina Labs

machinalabs.ai

Daedalus logo

Daedalus

daedalus.de

New Lab logo

New Lab

Strateos logo

Strateos

strateos.com

Synvivia logo

Synvivia

synvivia.com

Opentrons logo

Opentrons

opentrons.com

Multiply Labs - Quick Facts

Who are Multiply Labs' competitors?

Companies similar to Multiply Labs include Mytos, Orangewood Labs, Industrial Next and SkyMul.

When was Multiply Labs founded?

Multiply Labs was founded in 2016.

Where is Multiply Labs' headquarters located?

Multiply Labs' headquarters is located in San Francisco, CA, US.

When was Multiply Labs' last funding round?

Multiply Labs' most recent funding round was for $20M (USD) in April 2021.

How much has Multiply Labs raised to-date?

As of Apr 14, 2021, Multiply Labs has raised a total of $22.8M (USD).

How many employees does Multiply Labs have?

Multiply Labs has 44 employees as of Feb 5, 2024.

Multiply Labs - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Automation
  • Robotics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharma Manufacturing
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software